
U.S. - Medicaments of Penicillins, Streptomycins or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights
U.S.: Market for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof 2022
Market Size for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in the U.S.
The U.S. penicillins or streptomycins medicaments market expanded modestly to $X in 2021, growing by X% against the previous year. Over the period under review, consumption showed resilient growth. Penicillins or streptomycins medicaments consumption peaked at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.
Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in the U.S.
In value terms, penicillins or streptomycins medicaments production stood at $X in 2021. Over the period under review, production recorded a resilient increase. The pace of growth was the most pronounced in 2017 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2019; however, from 2020 to 2021, production stood at a somewhat lower figure.
Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof
Exports from the U.S.
In 2021, after two years of growth, there was significant decline in shipments abroad of medicaments of penicillins, streptomycins or derivatives thereof, when their volume decreased by -X% to X tons. Overall, exports, however, saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 when exports increased by X% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2020, and then dropped rapidly in the following year.
In value terms, penicillins or streptomycins medicaments exports declined notably to $X in 2021. In general, exports saw a deep downturn. The pace of growth was the most pronounced in 2016 with an increase of X%. Over the period under review, the exports attained the maximum at $X in 2012; however, from 2013 to 2021, the exports failed to regain momentum.
Exports by Country
Mexico (X tons) was the main destination for penicillins or streptomycins medicaments exports from the United States, with a X% share of total exports. Moreover, penicillins or streptomycins medicaments exports to Mexico exceeded the volume sent to the second major destination, Canada (X tons), twofold. The third position in this ranking was held by Belgium (X tons), with a X% share.
From 2012 to 2021, the average annual growth rate of volume to Mexico amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Canada (-X% per year) and Belgium (-X% per year).
In value terms, Saudi Arabia ($X), Belgium ($X) and Canada ($X) were the largest markets for penicillins or streptomycins medicaments exported from the United States worldwide, with a combined X% share of total exports. China, Mexico, France, Australia, Sweden, the United Arab Emirates, Taiwan (Chinese), Hong Kong SAR, the UK and South Korea lagged somewhat behind, together accounting for a further X, with a CAGR of +X%, saw the highest growth rate of the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2021, the average penicillins or streptomycins medicaments export price amounted to $X per ton, surging by X% against the previous year. Overall, the export price, however, continues to indicate a abrupt curtailment. Over the period under review, the average export prices attained the maximum at $X per ton in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.
Prices varied noticeably country of destination: the country with the highest price was Australia ($X per ton), while the average price for exports to Mexico ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Saudi Arabia (+X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof
Imports into the U.S.
In 2021, overseas purchases of medicaments of penicillins, streptomycins or derivatives thereof decreased by -X% to X tons, falling for the fifth consecutive year after three years of growth. Over the period under review, imports showed a pronounced reduction. The growth pace was the most rapid in 2016 with an increase of X%. As a result, imports reached the peak of X tons. From 2017 to 2021, the growth of imports remained at a lower figure.
In value terms, penicillins or streptomycins medicaments imports fell to $X in 2021. Overall, imports showed a perceptible setback. The most prominent rate of growth was recorded in 2016 when imports increased by X%. Over the period under review, imports attained the peak figure at $X in 2017; however, from 2018 to 2021, imports remained at a lower figure.
Imports by Country
India (X tons), Italy (X tons) and Austria (X tons) were the main suppliers of penicillins or streptomycins medicaments imports to the United States, together accounting for X% of total imports. These countries were followed by Jordan, Canada, Spain and China, which together accounted for a further X 2012 to 2021, the biggest increases were in Spain (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, India ($X), Italy ($X) and Austria ($X) appeared to be the largest penicillins or streptomycins medicaments suppliers to the United States, with a combined X% share of total imports. China, Jordan, Canada and Spain lagged somewhat behind, together comprising a further X, with a CAGR of +X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2021, the average penicillins or streptomycins medicaments import price amounted to $X per ton, remaining relatively unchanged against the previous year. In general, the import price, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2018 to 2021, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was China ($X per ton), while the price for Spain ($X per ton) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the prices for the other major suppliers experienced more modest paces of growth.
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2022 | 2012-2022 | 2023-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Making Data-Driven Decisions to Grow Your Business
A Quick Overview of Market Performance
Understanding the Current State of The Market and Its Prospects
Finding New Products to Diversify Your Business
Choosing the Best Countries to Establish Your Sustainable Supply Chain
Choosing the Best Countries to Boost Your Exports
The Latest Trends and Insights into The Industry
The Largest Import Supplying Countries
The Largest Destinations for Exports
The Largest Producers on The Market and Their Profiles
Recommended reports
This report provides an in-depth analysis of the global market for penicillins or streptomycins medicaments.
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the EU.
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in Asia.
This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in China.
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 22nd, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 8th, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, January 25th, 2022 @ 04:00 pm ET